The Weston Brain Institute has new funding opportunities available. Please have a close look:
All funding programs support translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging. As the Institute defines it, these diseases include:
* Alzheimer's disease
* Amyotrophic lateral sclerosis (ALS)
* Dementia with Lewy bodies
* Frontotemporal dementia
* Mild cognitive impairment as prodromal to one of the other listed diseases
* Multiple system atrophy
* Parkinson's disease
* Progressive supranuclear palsy
Submissions open: approximately August 2014 Seed funding (up to $150,000 for up to 18 months) for high-risk, high-reward, totally novel ideas.
One Time Program: 2014 Targeted Diseases: FTD and PSP*
Application deadline: Friday, June 6th, 2014 The Institute will commit up to $1.35 million to this program. Per project, funding can range from $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000. The Institute will commit up to $1.35 million to this program. Funding can range from $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000. research in frontotemporal dementia (FTD) and/or progressive supranuclear palsy (PSP).
Research in other overlapping tauopathies, such as corticobasal degeneration, is not supported at this time.
/sent on behalf of
Chris M. Anderson, PhD President - Winnipeg Chapter Society for Neuroscience Associate Professor and Director, Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Sciences Centre and University of Manitoba T: 204-318-2565 E: chris.anderson@med.umanitoba.camailto:chris.anderson@med.umanitoba.ca
Kelly Jorundson Executive Assistant Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund@sbrc.ca OR Kelly.jorundson@med.umanitoba.camailto:Kelly.jorundson@med.umanitoba.ca Website: www.sfn-manitoba.cahttp://www.sfn-manitoba.ca